Section Arrow
QGEN.NYSE
- Qiagen NV
Quotes are at least 15-min delayed:2026/09/01 15:37 EDT
Regular Hours
Last
 43.36
+0.07 (+0.16%)
Day High 
44.3 
Prev. Close
43.29 
1-M High
45.53 
Volume 
1.83M 
Bid
43.36
Ask
43.37
Day Low
43.08 
Open
44.23 
1-M Low
40.87 
Market Cap 
8.94B 
Currency 美元 
P/E 22 
%Yield 6.36 
10-SMA 43.47 
20-SMA 43.07 
50-SMA 41.42 
52-W High 57.815 
52-W Low 32.53 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.97/3.60
Enterprise Value
10.72B
Balance Sheet
Book Value Per Share
16.26
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
1.98B
Operating Revenue Per Share
10.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.86+2.3+50.44%-- 
PSNLPersonalis16.855+0.075+0.45%-- 
DHRDanaher Corp207-6.56-3.07%38.07PE
MYGNMyriad Genetics3.14-0.08-2.48%-- 
RVTYRevvity126.84-1.83-1.42%61.86PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.